In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.

Andrew and Graham also share their thoughts on how digitalization can be used alongside machine learning and artificial intelligence tools to assist with the innovation process through generating and enhancing the synthesis of novel chemical molecules.

Listen here to Part 1: Exploring Digital Transformation in Pharma R&D